Miromatrix Medical Inc.
DelistedCIK 1527096fmd_0DMJ995NN14RA7WHJ503AZA6BAManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2020 to Sep 30, 2023, 15 periods
| Line item | FY2020 | FY2021 | FY2022 |
|---|---|---|---|
| Total revenues | – | – | 1 |
| Cost of revenue | 1 | 1 | 1 |
| Gross profit | (0) | (0) | 0 |
| Research and development | 7 | 11 | 18 |
| Selling, general and administrative | 2 | 5 | 9 |
| Total operating expenses | 10 | 16 | 31 |
| Operating income | (10) | (17) | (30) |
| Interest and investment income | 0 | 0 | 0 |
| Income tax expense | 0 | 0 | 0 |
| Net income | (10) | (15) | (30) |